Rein Seensalu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Rein Seensalu has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
L. Bertilsson
Department of Medical Laboratory Sciences and Technology, Division of Clinical Pharmacology at Karolinska Institute, Huddinge Hospital, Sweden
2 shared publicationsM. Sagar
Center of Gastroenterology, Departments of Surgery and Medicine, Clinical Research Center, Sweden
2 shared publicationsA. Kjellin
Department of Surgery, Ersta Hospital, Sweden
1 shared publicationAkira Higashimori
1 shared publicationB Wikström
1 shared publicationC E Nord
1 shared publication
Latest Publications
- Open Access
- 27 November 2000
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 14 (11) , 1495-1502
Omeprazole and CYP2C19 polymorphism: effects of long-term treatment on gastrin, pepsinogen I, and chromogranin A in patients with acid related disorders
- 27 November 2000
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 14 (11) , 1495-1502
Open AccessOmeprazole and CYP2C19 polymorphism: effects of long-term treatment on gastrin, pepsinogen I, and chromogranin A in patients with acid related disorders
- Open Access
- 1 September 2000
- Published by Elsevier in Gastroenterology
- Vol. 119 (3) , 670-676
Effects of omeprazole on intragastric pH and plasma gastrin are dependent on the CYP2C19 polymorphism
- 1 September 2000
- Published by Elsevier in Gastroenterology
- Vol. 119 (3) , 670-676
Open AccessEffects of omeprazole on intragastric pH and plasma gastrin are dependent on the CYP2C19 polymorphism
- Open Access
- 15 April 1998
- Published by Elsevier in Gastroenterology
- Vol. 114, A273
The effect of omeprazole on intragastric pH and gastrin levels is determined by the CYP2C19 polymorphism more than by H. pylori infection in patients with acid related disease
- 15 April 1998
- Published by Elsevier in Gastroenterology
- Vol. 114, A273
Open AccessThe effect of omeprazole on intragastric pH and gastrin levels is determined by the CYP2C19 polymorphism more than by H. pylori infection in patients with acid related disease
- 1 January 1998
- Vol. 33 (1) , 39-43
Prolonged and profound acid inhibition is crucial in Helicobacter pylori treatment with a proton pump inhibitor combined with amoxicillin.
The aim was to investigate whether intragastric pH, meal-stimulated gastrin release, or demographic factors predict the outcome of Helicobacter pylori treatment. Thirty-six patients with H. pylori infection were investigated with 24-h intragastric pH registration and meal-stimulated gastrin release before and during treatment with 20 mg omeprazole twice daily and 750 mg amoxicillin twice daily for 14 days. The influence of age, sex, smoking, ethnic origin, pH, and gastrin on treatment outcome were analysed with logistic regression. Eradication of H. pylori was achieved in 18 of 34 (53%) patients. The univariate analysis showed that age, ethnic origin, more than 84.2% of the time with pH above 4, and continuous periods longer than 156 min with intragastric pH above 6 were significantly associated with successful treatment of H. pylori. In the multivariate analysis only the two pH variables were found to be independent factors for predicting treatment outcome. The outcome of H. pylori treatment with omeprazole and amoxicillin may depend on several factors, such as age, ethnic origin, and a pronounced acid suppression. However, the only factor of independent importance in this study was prolonged and profound acid inhibition.
- 1 January 1998
- Vol. 33 (1) , 39-43
Prolonged and profound acid inhibition is crucial in Helicobacter pylori treatment with a proton pump inhibitor combined with amoxicillin.
The aim was to investigate whether intragastric pH, meal-stimulated gastrin release, or demographic factors predict the outcome of Helicobacter pylori treatment. Thirty-six patients with H. pylori infection were investigated with 24-h intragastric pH registration and meal-stimulated gastrin release before and during treatment with 20 mg omeprazole twice daily and 750 mg amoxicillin twice daily for 14 days. The influence of age, sex, smoking, ethnic origin, pH, and gastrin on treatment outcome were analysed with logistic regression. Eradication of H. pylori was achieved in 18 of 34 (53%) patients. The univariate analysis showed that age, ethnic origin, more than 84.2% of the time with pH above 4, and continuous periods longer than 156 min with intragastric pH above 6 were significantly associated with successful treatment of H. pylori. In the multivariate analysis only the two pH variables were found to be independent factors for predicting treatment outcome. The outcome of H. pylori treatment with omeprazole and amoxicillin may depend on several factors, such as age, ethnic origin, and a pronounced acid suppression. However, the only factor of independent importance in this study was prolonged and profound acid inhibition.